Cambiar Investors’s Clorox CLX Stock Holding History

Cambiar Investors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.61M	Sell	27,384 -3,705	-12%	-$356K	0.11%	97
2026 Q1	$3.22M	Buy	+31,089	New	+$3.52M	0.15%	86

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cambiar Investors's CLX Position: Q2 2026 in Review

Cambiar Investors reduced its Clorox (CLX) stake by 12% in Q2 2026, selling an estimated $356K and leaving 27,384 shares worth $2.61M. The position accounts for 0.11% of the portfolio, ranked #97.

Cambiar Investors first reported a position in CLX in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.22M in Q1 2026. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Cambiar Investors held 27,384 shares of Clorox worth $2.61M as of Q2 2026.
Cambiar Investors sold 3,705 Clorox shares in Q2 2026, an estimated $356K.
Clorox made up 0.11% of Cambiar Investors's portfolio in Q2 2026, its #97 holding.
Cambiar Investors first reported a position in Clorox in Q1 2026 and has held it in 2 quarters since.
Cambiar Investors's Clorox position peaked at $3.22M in Q1 2026.
1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Cambiar Investors's 13F filing for Q2 2026, filed 31 Jul 2026.